II. Epidemiology
- Age: Peaks age 20-40 (20% of cases under age 18)
- Gender: Males affected more often than females
III. Pathophysiology
- Type IV Hypersensitivity Reaction (T Lymphocyte mediated) to various Antigens
- Self limited mucocutaneous reaction
IV. Types
- Erythema Multiforme Minor
- Now known simply as Erythema Multiforme
- Other forms below are distinct entities
-
Erythema Multiforme Major (Stevens Johnson Syndrome)
- Previously thought to be along same spectrum as minor
- Now thought to be distinct entity, with mucous membrane involvement
- May include Toxic Epidermal Necrolysis
V. Causes
- See Erythema Multiforme Causes
- Infections (90% of cases)
- Herpes Simplex Virus and Mycoplasma pneumoniae are most common
- Medications (10% of cases)
VI. Symptoms
- Lesion onset typically 3 to 5 days after initial exposure
- Onset up to 1 to 3 weeks after medication exposure
- Mild prodrome for 7-10 days may be present (more common with mucosal lesions, Erythema Multiforme Major)
- Malaise
- Fever
- Headache
- Rhinorrhea
- Cough
- Rash
- Develops 3-5 days after prodrome
- Lesions persist up to 1 to 2 weeks
- Rash may burn or itch
VII. Signs
- Distinctive Target or Iris skin lesion
- Starts as a dull erythematous (pink or red) Macule that becomes raised
- Centripetal spread (extremities to trunk) into target lesion over 3-5 days (often by day 2)
- Center: Dusky erythema or Vesicle
- Middle: Pale edematous ring
- Outer: Dark band of erythema
- Distribution: Symmetrical involvement with centripetal spread
- Onset on distal extremities (often dorsal hands, as well as palms and soles)
- Progress proximally (often extensor surfaces)
- Features absent in Erythema Multiforme Minor (contrast with EM Major and TEN)
- Oral Mucosal involvement is absent in Erythema Multiforme Minor
- Nikolsky Sign is absent in Erythema Multiforme Minor
- Non-toxic patient appearance
- Progresses
- Central necrosis
- Some lesions may coalesce into annular Plaques
- Healing
- Most lesions heal without complication
- Scarring or Postinflammatory Hyperpigmentation may occur
- Alternative presentations
VIII. Labs: None are necessary (use for differential diagnosis)
- Complete Blood Count
- Skin Biopsy (if diagnosis unclear)
- Biopsy with direct immunofluorescence distinguishes Bullous Diseases
- Consider evaluating for underlying etiology
- Herpes Simplex Virus
- Tzanck Preparation of skin lesion
- Mycoplasma pneumoniae
- Complement fixation
- Cold Agglutinins
- Chest XRay
- Herpes Simplex Virus
IX. Differential Diagnosis
- See Erythema Multiforme Differential Diagnosis
-
Erythema Multiforme Major
- Associated with mucosal lesions (distinguishes from Erythema Multiforme Major)
- Mucosal lesions (esp mouth) are seen in 25-60% of Erythema Multiforme cases
X. Management: Acute Erythema Multiforme Minor
- Elimination of precipitating factors
- Herpes Simplex Virus
- Mycoplasma pneumoniae
- Suspected drug or food item
- Mild Involvement: Supportive care
- Analgesics
- Oral Antihistamines
- Skin lesions
- Wet Dressings or soaks
- Topical Corticosteroids (questionable efficacy)
- Moderate Erythema Multiforme Minor
- Oral Acyclovir
- Prednisone (controversial, not typically recommended)
- Dose: 40-80 mg PO daily for 1-2 weeks, then taper
- Oral Lesions (Erythema Multiforme Major)
- See Erythema Multiforme Major
- Saline mouth rinses
- Home Precautions
- Return for fever, new systemic symptoms, large bullae or Oral Lesions
XI. Management: Recurent Erythema Multiforme Minor
- Background
- In some patients, may recur multiple times in one year (mean 6 episodes/year over 6-10 years)
- Conditions associated with recurrent Erythema Migrans (idiopathic in 60% of cases)
- Herpes Simplex Virus (thought to be related to many recurrence episodes, even without outbreak)
- Mycoplasma pneumoniae
- Hepatitis C
- Menstruation
- Systemic Antivirals
- Continue until lesion-free for 4 months
- Then taper dose gradually
- First-line
- Acyclovir 400 mg orally twice daily
- Second-line if Acyclovir ineffective
- Valacyclovir 500 mg orally twice daily
- Famciclovir 250 mg orally twice daily
- References
- Continue until lesion-free for 4 months
- Other agents in refractory cases
- Prescribed by Dermatology
- Agents (high rate of adverse effects)
XII. Course
- New lesions occur over 3-5 days
- Lesions persist for 1-2 weeks (non-migratory)
- Contrast with Urticaria that last <24 hours
- Resolves spontaneously in 3-5 weeks
- HSV related lesions typically resolve by 2 weeks
- Recurrence
- See above
XIII. References
- Long (2016) Crit Dec Emerg Med 30(7):3-10
- Sanelich (2024) Crit Dec Emerg Med 38(3): 16-17
- Lamoreux (2006) Am Fam Physician 74:1883-8 [PubMed]
- Leaute-Labreze (2000) Arch Dis Child 83:347-52 [PubMed]
- Trayes (2019) Am Fam Physician 100(2): 82-8 [PubMed]
- Williams (2005) Dent Clin North Am 49:67-76 [PubMed]